GB2154735A - Reagent for determining blood glucose content - Google Patents

Reagent for determining blood glucose content Download PDF

Info

Publication number
GB2154735A
GB2154735A GB08501049A GB8501049A GB2154735A GB 2154735 A GB2154735 A GB 2154735A GB 08501049 A GB08501049 A GB 08501049A GB 8501049 A GB8501049 A GB 8501049A GB 2154735 A GB2154735 A GB 2154735A
Authority
GB
United Kingdom
Prior art keywords
reagent
glucose
active agent
glucose content
litre
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08501049A
Other versions
GB2154735B (en
GB8501049D0 (en
Inventor
Umberto Basagni
Francesco Bonicolini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini SAS
Original Assignee
Menarini SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT47603/84A external-priority patent/IT1177513B/en
Application filed by Menarini SAS filed Critical Menarini SAS
Publication of GB8501049D0 publication Critical patent/GB8501049D0/en
Publication of GB2154735A publication Critical patent/GB2154735A/en
Application granted granted Critical
Publication of GB2154735B publication Critical patent/GB2154735B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A stable and ready to use liquid reagent for determining the glucose content in blood comprises a glucose-oxidase, (free from catalse), and a nonionic surface-active agent, such as, for example, the polyoxyethylene derivatives, hydroxypolyethylene ethoxydodecane, or the lauryl ether of polyoxyethylene-glycol, as a stabilizer.

Description

SPECIFICATION Reagent for determining blood glucose content The present invention relates to a ready to use liquid reagent for determing the glucose content in blood. More particularly, the invention relates to a stable liquid reagent, in a single kit ready to use form, comprising a glucose-oxidase free from catalase and a non ionic surface-active agent.
It is known that the simplest and most used methods for determining the glucose content in blood (plasma or serum), are founded on the Trinder method or on variations of the same.
The glucose content in blood can be determined by means of the glucose-oxidase and the coloured Trinder reaction according to the following steps:
-D-g1ucopyranose + H20 (64S )
glucono- 6-lactone.H2O2.
3) 2H202*phenol+4-aminophenazone
(p-benzoqulnonemonoimino)-phenazone + 4H20.
The reagent used in the above consists of two components: a) A suitably buffered enzymatic component (glucose-oxidase-peroxidase); b) A chromogen, specifically 4-aminophenazone pluse phenol (the latter can be replaced by its derivatives, hence the variations on the original method introduced by Trinder, who first used phenol).
All the reagents according to this method must be reconstituted at the moment of their use in a single operating reagent, having, when reconstituted, limited stability. Thus, it should be noted that such a reagent, when reconstituted, presents the disadvantage of a guaranteed expiration date not longer than 60 days and of about 30 days on average. Such a reagent cannot therefore really be regarded as a ready to use reagent due to its limited stability.
At present, two methods for reconstituting the operating reagent are known: I) By adding water to a premixed enzyme-chromogen system; II) By mixing the enzymatic component and the chromogen, which, in this case, have been kept apart.
However, in all cases, the user is required to manipulate the product. This operation, even if it is simple, frequently causes mistakes because in the reagent's preparation some technical problems affecting the system's validity can arise.
In case I, when the operation reagent is reconstituted, high-purity distilled water is required, while only deionized water, not completely free from chlorine, is available in laboratories for clinical tests (a common inconvenince, particularly in summer time).
In case II during the pouring off step a loss of one of the two reagents frequently occurs due to outflow of one of them, or, more frequently, due to the incomplete dripping of one of the reagents from its bottle. In such cases, the operating reagent often has a final concentration different from the desired one.
Disadvantages occur also when the adopted procedure prevents the obtaining of a complete mixture of the solute and the solvent, as frequently occurs if the enzyme is provided as an anhydrous powder together with the buffer, which often being a phosphate buffer, is only slightly soluble.
When powdered reagents are used, as frequently occurs, it must be taken into account that the powdered ingredients proportions can be stated within a very broad range and that incomplete homogeneity can derive therefrom, even within the same preparation lot. This fact is even clearer when lyophilized enzymes are used, because, as is known, the lyophilization process may often heterogeneously reduce enzymatic activity (the single bottle's position, with respect to its place on the plates during the freezing step, is surely an influence), so that the final concentrations (as enzymatic activity) can be very different from each other.
In addition to these technical inconveniences affecting the system's reliability, the reagents so far employed have very high production costs.
The present production methods include two possibilities: a) anhydrous powders b) lyophiles.
In cases a) production requires a special humidity-controlled room and expensive plants where operators are exposed to serious risks due to hard work conditions. Thus, the use of such enzymes as powders, and especially the presence of sodium azide and of the various buffers, can cause damage, sometimes irreversible, to the respiratory organs of operators if they are exposed for a long time. Moreover, it has been noted that some people, after some years of such work, become sensitized to said enzymes and subject to consequent injuries.
In cases b), the use of lyophilizers calls for large amounts of electrical energy and water, in addition to the plants extinction costs.
It is therefore clear that it would be most important to have available a reagent for determining glucose content in blood which avoids the delicate reconstitution operations mentioned before and the expensive production techniques and the dangers for staff and the long lead-times (minimum times for reagent set-up).
The present invention is based upon the surprising discovery that these problems may be solved by using as a reagent a glucose-oxidase (GOD), completely free from catalase, combined with stabilizers consisting of nonionic surface-active agents.
This combination provides a stable unitary liquid reagent ready to use. The homogeneous concentration of the single components' enzymatic activities appears to be particularly favourable, because the reaction rate, which can be expressed as AA At of the coloured chromogen (A = absorbance or extinction), is particularly related to the ratio u.i/litre of glucose-oxidase, where u.i. is, as is know, the amount of enzyme which oxidases 1 mole of glucose per min at 25"C and pH = 7.0 (sodium phosphate buffer).
On this subject it is to be observed that sometimes remarkable differences in enzymatic activities can be found in reagents at present on the market, even amongst bottles from the same lot. Consequently there are some problems in the technique known as "Fixed Time", which can, in contrast, be properly carried out with a reagent linke that according to this invention whose invariability between bottles is substantially assured.
For correct setting up of such a technique it is necessary that the glucose oxidation by "GOD" follow psuedo-first-order kinetics with respect to glucose.
This causes a series of coupled reactions, to which the kinetics principle of fixed time measurements can be applied.
The above-mentioned technique can be applied to the reagent according to this invention, making it particularly suitable for fast analyzers that allow a considerable saving in time.
It is therefore a specific object of this invention to provide a ready to use liquid reagent for determining the glucose content in blood which comprises a glucose-oxidase free from catalase and a nonionic surface-active agent as a stabilizer.
In a preferred embodiment according to the invention a glucose-oxidase amount of from 9,000 to 40,000 u.i/litre and a nonionic surface-active agent amount of from 5 mg/litre to 50 g/litre are employed.
A polyoxyethylene (POE) nonionic surface-active agent is preferably employed, such as, for example, POE-tridecyl alcohol, POE-nonylphenol, etc. (RENEX), POE-octylphenol (TRITON) and POE-lauryl-, cetyl-, stearyl-, oleyl-alcohol (BRIJ).
Similarly, very good results are obtained by employing, as a surface-active agent, hydroxypolyethylene-etoxydodecane (C,2H25-(0-2J4)n-OH) or the lauryl ether of polyoxyethylenglycol (TH ES IT).
It is quite clear and must be pointed out that the absence of catalase was not taken into account either by Trinder or by other authors.
For illustrative and not for limitative purposes the following compositions are now described: COMPOSITION A Amounts referred to 1000ml of reagent GOD 9,000-40,000 u.i.
Peroxidase 300-3,000 u.i.
4-aminoantipyrine 0.1-1.5 mmoles Phenol 1.5-15.5 mmoles Phosphate buffer pH 6.5-11.4 POE-lauryl alcohol (Brij 35), at a concentration of from 5 mg/litre, was employed in this composition as a surface-active agent.
COMPOSITION B Amount referred to 1,000 ml of reagent GOD 9,000-40,000 u.i.
Peroxidase 300-3,000 u.i.
4-aminoantipyrine 0.1-1.5 mmoles phenol 1.5-15.5 mmoles Phosphate buffer pH 6.5-11.4 POE-octylphenol (Triton-X100), at a concentration of from 5 mg/litre to 50 g/litre, was employed in this composition as a surface-active agent.
As can be seen from Fig. 1 of the accompanying drawings, wherein the absorbance values are plotted vs. the reaction times, the resulting reaction kinetics for the compositions A and B, measured on Perkin-Elmer, are exactly alike even when the surface-active agent employed is changed .
In order to demonstrate the unalterability of product quality, Fig. 2 of the accompanying drawings depicts the absorbance of a reagent sample of the kind used in composition A prepared in February 1 983 but not tested until January 1 984. Besides noting how the curve is in accordance with theory, even at high concentration (500 mg/dl), it should be noted that the reaction is completely accomplished within an estimated 10 minutes.
This result was obtained by using a reagent lot as herein before disclosed which was stored, during the noted period, under stress test conditions (in fact a transparent vessel was used instead of the usual opaque vessel, which vessel was often opened and closed). It is further to be noted that the absorbance of white against H2O is only 0.1 28, that is quite an acceptable value from the moment that, moreover, such a reagent increases its absorbance under the direct action of the light.
A graphic demonstration pertinent to the product used in obtained the results of Fig. 2 is given in Fig. 3 of the accompanying drawings, wherein the absorbance (A) is plotted as a function of the concentration (c.St.) of the standard employed (abscissa). This diagram clearly shows the perfect linearity of the reagent up to a maximum concentration of 500 mg/litre. This straight was line plotted by computer utilizing a series of standards of 25, 50, 100, 200, 400, 500 mg/litre. The proportion of reagent to sample was 1,000 litre/10 litre; the reaction time was 10 minutes. The colour remains stable for about 1 hour.
The present invention has been disclosed with particular reference to some specific embodiments, but it is to be understood that modifications and changes can be introduced in the above disclosure by those skilled in the art without departing from its true spirit and scope.

Claims (7)

1. A ready to use liquid reagent for determining the glucose content of blood comprising a glucose-oxidase substantially free from catalase and a nonionic surface-active agent as a stabilizer.
2. A reagent as claimed in claim 1, wherein the glucose-oxidase is present in an amount of from 9,000 to 40,000 u;i./litre and the nonionic surface-active agent is present in an amount of from 5 mg/litre-50 g/litre.
3. A reagent as claimed in claim 1 or claim 2, wherein the nonionic surface-active agent is a polyoxyethylene surface-active agent.
4. A reagent as claimed in claim 3, wherein the non ionic polyoxyethylene surface-active agent is POE-lauryl alcohol or POE-octylphenol.
5. A stable ready to use liquid reagent for determining the glucose content in blood and substantially as hereinbefore described.
6. A ready to use liquid reagent for determining the glucose content in blood and substantially as hereinbefore described either as "Composition A" or as "Composition B".
7. The use of a liquid composition containing a glucose-oxidase substantially free from catalase and a nonionic surface-active agent in the analysis of glucose content in a sample, e.g.
in a blood sample.
GB08501049A 1984-01-27 1985-01-16 Reagent for determining blood glucose content Expired GB2154735B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT47603/84A IT1177513B (en) 1984-01-27 1984-01-27 READY TO USE LIQUID REACTIVE FOR THE DETERMINATION OF THE CONTENT OF BLOOD IN THE BLOOD
US58228184A 1984-02-22 1984-02-22

Publications (3)

Publication Number Publication Date
GB8501049D0 GB8501049D0 (en) 1985-02-20
GB2154735A true GB2154735A (en) 1985-09-11
GB2154735B GB2154735B (en) 1987-07-15

Family

ID=26329206

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08501049A Expired GB2154735B (en) 1984-01-27 1985-01-16 Reagent for determining blood glucose content

Country Status (1)

Country Link
GB (1) GB2154735B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863400A (en) * 1994-04-14 1999-01-26 Usf Filtration & Separations Group Inc. Electrochemical cells
US5942102A (en) * 1995-11-16 1999-08-24 Usf Filtration And Separations Group Inc. Electrochemical method
US5980709A (en) * 1995-04-12 1999-11-09 Usf Filtration And Separations Group Method of defining an electrode area
US6284125B1 (en) 1995-06-19 2001-09-04 Usf Filtration And Separations Group, Inc. Electrochemical cell
US6413410B1 (en) 1996-06-19 2002-07-02 Lifescan, Inc. Electrochemical cell
US6521110B1 (en) 1995-11-16 2003-02-18 Lifescan, Inc. Electrochemical cell
US6863801B2 (en) 1995-11-16 2005-03-08 Lifescan, Inc. Electrochemical cell
US8449740B2 (en) 2006-03-31 2013-05-28 Lifescan, Inc. Systems and methods for discriminating control solution from a physiological sample
US9739749B2 (en) 2008-01-17 2017-08-22 Lifescan, Inc. System and method for measuring an analyte in a sample
US9784707B2 (en) 2008-06-09 2017-10-10 Lifescan, Inc. System and method for measuring an analyte in a sample

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638415B1 (en) 1995-11-16 2003-10-28 Lifescan, Inc. Antioxidant sensor
US7431820B2 (en) 2001-10-10 2008-10-07 Lifescan, Inc. Electrochemical cell
US8778168B2 (en) 2007-09-28 2014-07-15 Lifescan, Inc. Systems and methods of discriminating control solution from a physiological sample

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012184A1 (en) * 1978-11-22 1980-06-25 MERCK PATENT GmbH Hemolytic solution, application of such a solution for determining the presence of glucose in blood, and hemolytic process
EP0016946A1 (en) * 1979-03-22 1980-10-15 Roche Diagnostics GmbH Process and reagent for the activation of cholesterol esterase
EP0024578A1 (en) * 1979-08-23 1981-03-11 Ivan Endre Modrovich Method of stabilizing an enzyme solution for use in total cholesterol determination, stabilized solution and test kit therefor
GB1592632A (en) * 1977-02-03 1981-07-08 Eastman Kodak Co Hydrolysis process for protein-bound cholesterol esters
EP0044432A2 (en) * 1980-07-10 1982-01-27 Ivan Endre Modrovich Stabilized enzymatic solutions and method for determining total cholesterol in human serum
WO1983003254A1 (en) * 1982-03-11 1983-09-29 Arthur Babson Stabilization of diazonium salt solutions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592632A (en) * 1977-02-03 1981-07-08 Eastman Kodak Co Hydrolysis process for protein-bound cholesterol esters
EP0012184A1 (en) * 1978-11-22 1980-06-25 MERCK PATENT GmbH Hemolytic solution, application of such a solution for determining the presence of glucose in blood, and hemolytic process
EP0016946A1 (en) * 1979-03-22 1980-10-15 Roche Diagnostics GmbH Process and reagent for the activation of cholesterol esterase
EP0024578A1 (en) * 1979-08-23 1981-03-11 Ivan Endre Modrovich Method of stabilizing an enzyme solution for use in total cholesterol determination, stabilized solution and test kit therefor
EP0044432A2 (en) * 1980-07-10 1982-01-27 Ivan Endre Modrovich Stabilized enzymatic solutions and method for determining total cholesterol in human serum
WO1983003254A1 (en) * 1982-03-11 1983-09-29 Arthur Babson Stabilization of diazonium salt solutions

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863400A (en) * 1994-04-14 1999-01-26 Usf Filtration & Separations Group Inc. Electrochemical cells
US5980709A (en) * 1995-04-12 1999-11-09 Usf Filtration And Separations Group Method of defining an electrode area
USRE44330E1 (en) 1995-06-19 2013-07-02 Lifescan Inc. Electrochemical cell
US6284125B1 (en) 1995-06-19 2001-09-04 Usf Filtration And Separations Group, Inc. Electrochemical cell
US8597480B2 (en) 1995-06-19 2013-12-03 Lifescan, Inc. Electrochemical cell
US8075760B2 (en) 1995-06-19 2011-12-13 Lifescan, Inc. Electrochemical cell
US8101056B2 (en) 1995-06-19 2012-01-24 Lifescan, Inc. Electrochemical cell
US5942102A (en) * 1995-11-16 1999-08-24 Usf Filtration And Separations Group Inc. Electrochemical method
US6179979B1 (en) 1995-11-16 2001-01-30 Usf Filtration & Separations Group, Inc. Electrochemical cell
US6521110B1 (en) 1995-11-16 2003-02-18 Lifescan, Inc. Electrochemical cell
US6863801B2 (en) 1995-11-16 2005-03-08 Lifescan, Inc. Electrochemical cell
USRE42567E1 (en) 1995-11-16 2011-07-26 Lifescan, Inc. Electrochemical cell
US6960289B2 (en) 1996-06-19 2005-11-01 Lifescan, Inc. Electrochemical cell
US6413410B1 (en) 1996-06-19 2002-07-02 Lifescan, Inc. Electrochemical cell
US9075004B2 (en) 1996-06-19 2015-07-07 Lifescan, Inc. Electrochemical cell
US8449740B2 (en) 2006-03-31 2013-05-28 Lifescan, Inc. Systems and methods for discriminating control solution from a physiological sample
US9739749B2 (en) 2008-01-17 2017-08-22 Lifescan, Inc. System and method for measuring an analyte in a sample
US9784707B2 (en) 2008-06-09 2017-10-10 Lifescan, Inc. System and method for measuring an analyte in a sample

Also Published As

Publication number Publication date
GB2154735B (en) 1987-07-15
GB8501049D0 (en) 1985-02-20

Similar Documents

Publication Publication Date Title
US5077199A (en) Ready to use liquid reagent for determining the glucose content in blood
Allain et al. Enzymatic determination of total serum cholesterol
Bergmeyer et al. Glutamate-oxaloacetate transaminase
US4517287A (en) Method and reagent for the enzymatic determination of enzyme substrates
GB2154735A (en) Reagent for determining blood glucose content
Akimoto et al. Luminol chemiluminescence reaction catalyzed by a microbial peroxidase
SU664536A3 (en) Reagent for determining cholesterin
JPS5592698A (en) Test strip for glucose determination
Morris et al. Characterization of the purified vitamin K-dependent gamma-glutamyl carboxylase.
JPH0640836B2 (en) Methods and formulations for avoiding protein substrate effects in the specific determination of serum fructosamine content in blood or samples derived from blood
EP0215170B1 (en) Single color reading method for determining fructosamine
JP4889396B2 (en) Method for stabilizing leuco dyes
CA1154366A (en) Enzymatic method and stabilized solutions for determining total cholesterol in human serum
Mamoru et al. A new colorimetric method for determination of serum glucose
US5270194A (en) Stabilized glucose oxidase from Aspergillus Niger
Dutton et al. [49] Assays for UDPglucuronyltransferase activities
NO780822L (en) PEROXYDASE DETERMINATION.
GB1429525A (en) Process and reagent for the quantitative determination of cholesterol
Majkić et al. Determination of free and esterified cholesterol by a kinetic method: I. The introduction of the enzymatic method with 2, 2'-azino-di-3 [ethyl-benzthiazolin sulfonic acid (6)](ABTS)
US3864085A (en) Glutathione reagent and test method
EP0044432B1 (en) Stabilized enzymatic solutions and method for determining total cholesterol in human serum
Cooper et al. The estimation of serum acid phosphatase using α-naphthyl phosphate as substrate: observations on the use of Fast Red TR salt in the assay
CA1079615A (en) Composition for the enzymic determination of glucose
Welshman et al. Colorimetric estimation of lactic dehydrogenase isoenzymes by urea inhibition
CN110261337A (en) A kind of total bile acid detection reagent

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930116